• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

This product is currently not available for purchase.

RELATED PRODUCTS

  • Medicated Skin Care in Georgia - Product Thumbnail Image Medicated Skin Care in Georgia

    Medicated Skin Care in Georgia

    • Published: May 2012
    • Region: Georgia
    FROM
  • Medicated Skin Care in Belgium - Product Thumbnail Image Medicated Skin Care in Belgium

    Medicated Skin Care in Belgium

    • Language: English
    • Published: June 2012
    • Region: Belgium
    FROM
  • Medicated Skin Care in Sweden - Product Thumbnail Image Medicated Skin Care in Sweden

    Medicated Skin Care in Sweden

    • Language: English
    • 26 Pages
    • Published: June 2012
    • Region: Sweden
    FROM
  • Medicated Skin Care in Hungary - Product Thumbnail Image Medicated Skin Care in Hungary

    Medicated Skin Care in Hungary

    • Language: English
    • Published: July 2012
    • Region: Hungary
    FROM
  • Medicated Skin Care in Algeria - Product Thumbnail Image Medicated Skin Care in Algeria

    Medicated Skin Care in Algeria

    • Language: English
    • Published: July 2012
    • Region: Algeria
    FROM
  • Medicated Skin Care in Uzbekistan - Product Thumbnail Image Medicated Skin Care in Uzbekistan

    Medicated Skin Care in Uzbekistan

    • Language: English
    • Published: August 2012
    • Region: Uzbekistan
    FROM
  • Medicated Skin Care in Vietnam - Product Thumbnail Image Medicated Skin Care in Vietnam

    Medicated Skin Care in Vietnam

    • Language: English
    • Published: August 2012
    • Region: Vietnam
    FROM
  • Medicated Skin Care in Portugal - Product Thumbnail Image Medicated Skin Care in Portugal

    Medicated Skin Care in Portugal

    • Language: English
    • Published: September 2012
    • Region: Portugal
    FROM
  • Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

    Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

    • Language: English
    • 1677 Pages
    • Published: July 2014
    • Region: Global
    FROM
  • Skin Lighteners - Global Strategic Business Report - Product Thumbnail Image Skin Lighteners - Global Strategic Business Report

    Skin Lighteners - Global Strategic Business Report

    • Language: English
    • 211 Pages
    • Published: January 2015
    • Region: Global
    FROM
Medicated Skin Products Market in Venezuela to 2014 (OTC Healthcare) Product Image

Medicated Skin Products Market in Venezuela to 2014 (OTC Healthcare)

  • ID: 1583467
  • February 2011
  • Region: Venezuela
  • 28 pages
  • Datamonitor

Introduction

This databook provides key data and information on the Medicated Skin Products Market in Venezuela (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
-Category level company and brand share as well as distribution share information for 2007 and 2008

Highlights

The medicated skin products category was valued at VEF21,636m ($10.1m) in 2009, representing a CAGR of 8.6% since 2004.

By the end of 2014, the medicated skin products category will be worth VEF27,867.1m ($13m), with an expected CAGR of 5.2% between 2009 and 2014.

The medicated skin products market was led by anti-bacterials (representing 31.7% of the total value) followed by disinfectants and other medicated skin products, with a 25% and 16.9% market share, respectively. Anti-fungals and acne treatments constitute the remaining segments with a 15.9% and 10.5% market share, respectively.

Avon Products, Inc. is the market leader with a 26.1% share of the market.

Reasons to Purchase

-Develop business strategies by understanding the quantitative trends within the Medicated Skin Products Market in Venezuela (OTC Healthcare)

-Design effective marketing and sales strategies by identifying key market categories and segments

-Identify key players within the market to plan lucrative M&A, partnerships and agreements

Note: Product cover images may vary from those shown



Chapter 1 Executive Summary
Summary category level: medicated skin products

Chapter 2 Definition

Chapter 3 Category Analysis: Medicated Skin Products
Value analysis (Venezuelan Bolivar Fuerte), 2004-09
Value analysis (Venezuelan Bolivar Fuerte), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 4 Macroeconomic Profile
Macroeconomic Indicators

Chapter 5 Research Methodology
Methodology overview
Secondary research
Market modeling
Creating an initial data model
Revising the initial data model
Creating a final estimate
Creating demographic value splits
Primary research
Data finalization
Ongoing research

LIST OF FIGURES
Figure 1: Medicated skin products, Venezuela, value by segment (VEFm), 2004-14
Figure 2: Medicated skin products, Venezuela, category growth comparison, by value, 2004-14
Figure 3: Medicated skin products, Venezuela, company share by value (%), 2008-09
Figure 4: Medicated skin products, Venezuela, distribution channels by value (%), 2008-09
Figure 5: Annual data review process

LIST OF TABLES
Table 1: Medicated skin products category definitions
Table 2: Medicated skin products distribution channels
Table 3: Medicated skin products, Venezuela, value by segment (VEFm), 2004-09
Table 4: Medicated skin products, Venezuela, value forecast by segment (VEFm), 2009-14
Table 5: Medicated skin products, Venezuela, value by segment ($m), 2004-09
Table 6: Medicated skin products, Venezuela, value forecast by segment ($m), 2009-14
Table 7: Medicated skin products, Venezuela, brand share by value (%), 2008-09
Table 8: Medicated skin products, Venezuela, value by brand (VEFm), 2008-09
Table 9: Medicated skin products, Venezuela, company share by value (%), 2008-09
Table 10: Medicated skin products, Venezuela, value by company (VEFm), 2008-09
Table 11: Medicated skin products, Venezuela, distribution channels by value (%), 2008-09
Table 12: Medicated skin products, Venezuela, value by distribution channel (VEFm), 2008-09
Table 13: Venezuela population, by age group, 2004-09 (millions)
Table 14: Venezuela population forecast, by age group, 2009-14 (millions)
Table 15: Venezuela population, by gender, 2004-09 (millions)
Table 16: Venezuela population forecast, by gender, 2009-14 (millions)
Table 17: Venezuela nominal GDP, 2004-09 (VEFbn, nominal prices)
Table 18: Venezuela nominal GDP forecast, 2009-14 (VEFbn, nominal prices)
Table 19: Venezuela real GDP, 2004-09 (VEFbn, 2000 prices)
Table 20: Venezuela real GDP forecast, 2009-14 (VEFbn, 2000 prices)
Table 21: Venezuela real GDP, 2004-09 ($bn, 2000 prices)
Table 22: Venezuela real GDP forecast, 2009-14 ($bn, 2000 prices)
Table 23: Venezuela consumer price index, 2004-09 (2000=100)
Table 24: Venezuela consumer price index, 2009-14 (2000=100)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

Our Clients

Beiersdorf AG GlaxoSmithKline PLC Procter & Gamble Co. Maybelline LLC. Arbonne International LLC. Galderma S.A.